Bayer Must Allow Cancer Generic In India, Court Rules
An Indian patent court has for the first time forced a pharmaceutical company to open up the generic market for a costly cancer drug, ordering Bayer AG to permit a cheaper...To view the full article, register now.
Already a subscriber? Click here to view full article